Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Diabetologia
|
February 3, 2009
TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study
E S Stolerman, A K Manning, J B McAteer, et al.
Diabetologia
|
May 10, 2003
A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study
C I M Panhuysen, L A Cupples, P W F Wilson, et al.
Current Medical Research and Opinion
|
November 2, 2006
The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients
C Crivera, D C Suh, E S Huang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance
C Hadigan, J B Meigs, J Rabe, et al.
International Journal of Obesity (2005)
|
June 1, 2005
Health consequences of obesity in the elderly: a review of four unresolved questions
M Zamboni, G Mazzali, E Zoico, et al.
Diabetologia
|
June 6, 2006
Correlates of health-related quality of life in type 2 diabetes
D J Wexler, R W Grant, E Wittenberg, et al.
Diabetes Care
|
June 2, 2000
Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study
J B Meigs, J M Ordovas, L A Cupples, et al.
Diabetes Care
|
July 27, 2001
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study
J B Meigs, P F Jacques, J Selhub, et al.
Diabetologia
|
June 21, 2005
The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study
A Herbert, C Liu, S Karamohamed, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 27, 2004
Clinical inertia in the management of Type 2 diabetes metabolic risk factors
R W Grant, E Cagliero, A K Dubey, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Diabetologia
|
February 3, 2009
TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study
E S Stolerman, A K Manning, J B McAteer, et al.
Diabetologia
|
May 10, 2003
A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study
C I M Panhuysen, L A Cupples, P W F Wilson, et al.
Current Medical Research and Opinion
|
November 2, 2006
The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients
C Crivera, D C Suh, E S Huang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance
C Hadigan, J B Meigs, J Rabe, et al.
International Journal of Obesity (2005)
|
June 1, 2005
Health consequences of obesity in the elderly: a review of four unresolved questions
M Zamboni, G Mazzali, E Zoico, et al.
Diabetologia
|
June 6, 2006
Correlates of health-related quality of life in type 2 diabetes
D J Wexler, R W Grant, E Wittenberg, et al.
Diabetes Care
|
June 2, 2000
Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study
J B Meigs, J M Ordovas, L A Cupples, et al.
Diabetes Care
|
July 27, 2001
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study
J B Meigs, P F Jacques, J Selhub, et al.
Diabetologia
|
June 21, 2005
The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study
A Herbert, C Liu, S Karamohamed, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 27, 2004
Clinical inertia in the management of Type 2 diabetes metabolic risk factors
R W Grant, E Cagliero, A K Dubey, et al.
Page
of 6